Medicare Enrolled
Dr. Hoyt Doak, M.D.
Urology Physician · New Bern, NC
Practice pattern: Clinical Cardiology
— Primarily office-based clinical cardiology
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Doak from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Doak?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Doak
Dr. Hoyt Doak is an urology physician in New Bern, NC, with 17 years of NPI registration. Based on federal Medicare data, Dr. Doak performed 3,059 Medicare services across 1,998 unique beneficiaries.
Between the years covered by Open Payments, Dr. Doak received a total of $2,457 from 31 pharmaceutical and/or device companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in urology physician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Doak is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 17 years in practice
▲ Top 29% volume in NC
$2,457 industry payments
Medicare Practice Summary
Medicare Utilization ↗3,059
Medicare services
Top 29% in NC for urology physician
1,998
Unique beneficiaries
$48
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~180 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
760 | $3 | $26 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
336 | $89 | $224 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 260 | $3 | $20 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
258 | $64 | $166 |
| Bladder ultrasound after voiding An ultrasound scan performed after urination to measure the amount of urine remaining in the bladder. |
252 | $7 | $121 |
| Cystourethroscopy A diagnostic exam of the bladder and urethra using an endoscope to visually inspect the urinary tract. |
124 | $177 | $543 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
122 | $111 | $356 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
119 | $8 | $20 |
| PSA test (prostate cancer screening) | 92 | $18 | $98 |
| Ceftriaxone antibiotic injection This code represents the administration of ceftriaxone sodium, an antibiotic medication. The charge is calculated for every 250 mg of the drug administered. |
88 | $0 | $23 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 82 | $134 | $503 |
| Urine culture, bacterial colony count A laboratory test that measures the number of bacteria growing in a urine sample to help identify infections. |
52 | $8 | $52 |
| Hospital follow-up visit, moderate complexity Follow-up hospital visit for an existing patient involving moderate medical decision making. The visit requires at least 35 minutes of time spent on the date of service. |
49 | $60 | $177 |
| Simple insertion of temporary bladder tube A procedure to place a temporary tube into the bladder. This allows for the drainage of urine from the bladder. |
47 | $44 | $284 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
41 | $132 | $325 |
| Bladder instillation of anti-cancer drug A procedure where an anti-cancer medication is introduced directly into the bladder. This method delivers the treatment locally to the bladder tissue. |
35 | $64 | $304 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
34 | $10 | $51 |
| Ultrasound guidance for needle placement Use of ultrasound imaging to guide the precise placement of a needle during a medical procedure. |
25 | $45 | $421 |
| Abdominal X-ray, 1 view An X-ray image of the abdomen taken from a single angle to visualize internal structures. |
24 | $15 | $104 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
23 | $25 | $119 |
| Electronic assessment of bladder emptying A test that uses electronic monitoring to evaluate how well the bladder empties urine. |
22 | $6 | $178 |
| Ureteral stent insertion via endoscope A flexible tube is inserted into the ureter using an endoscope to keep the passage open and allow urine to flow from the kidney to the bladder. |
22 | $81 | $1,555 |
| Basic metabolic blood panel A blood test that measures a group of basic chemicals, including total calcium levels. |
22 | $8 | $55 |
| Prostate gland biopsy A procedure to remove small samples of tissue from the prostate gland for laboratory examination. |
21 | $164 | $544 |
| Transrectal ultrasound of the pelvis An ultrasound imaging procedure where a probe is inserted into the rectum to visualize pelvic structures. |
21 | $104 | $358 |
| Endoscopic removal of foreign body, stone, or stent from urethra or bladder A procedure to remove a foreign object, stone, or stent from the urethra or bladder using an endoscope. The endoscope is a thin tube with a camera inserted into the urinary tract to locate and extract the item. |
20 | $244 | $724 |
| Initial hospital admission, low complexity Initial hospital inpatient or observation care for a new patient involving straightforward or low-level medical decision making, with at least 40 minutes total time on the date of the encounter. |
20 | $55 | $245 |
| Initial hospital admission, moderate complexity Initial hospital inpatient or observation care for a new patient involving moderate-level medical decision making, with at least 55 minutes total time on the date of the encounter. |
17 | $101 | $336 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
13 | $8 | $58 |
| Endoscopic removal of pelvic lymph nodes, bilateral A surgical procedure to remove lymph nodes from both sides of the pelvis using an endoscope. This minimally invasive technique involves making small incisions to access and excise the tissue. |
12 | $183 | $3,354 |
| Surgical removal of prostate and lymph nodes This procedure involves the surgical removal of the prostate gland and surrounding lymph nodes using an endoscope. |
12 | $645 | $5,100 |
| Total testosterone level test A blood test that measures the total amount of testosterone in your body. This hormone is important for various bodily functions in both men and women. |
12 | $25 | $150 |
| Transurethral prostate removal with electrocautery This procedure involves removing the prostate gland through the urethra using an endoscope and an electrocautery knife to control bleeding. |
11 | $541 | $3,573 |
| Complete ultrasound of retroperitoneum An ultrasound examination of the structures located behind the abdominal cavity. |
11 | $45 | $232 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
1.4% high complexity
24.0% medium
74.6% routine
Industry Payment Transparency
Open Payments through 2024 ↗$2,457
Total received (2018-2024)
Avg $351/year across 7 years
Top 50% in NC for urology physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
31
Companies
93
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,117 (86.1%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$341 (13.9%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$384
2023
$192
2022
$249
2021
$90
2020
$62
2019
$440
2018
$1,041
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
PROCEPT BioRobotics Corporation
$117
Sumitomo Pharma America, Inc.
$100
Dendreon Pharmaceuticals LLC
$59
Teleflex LLC
$56
Boston Scientific Corporation
$33
Endo Pharmaceuticals Inc.
$19
Top 3 companies account for 71.9% of 2024 payments
All-time payments by company (2018-2024) ›
NeoTract Inc.
$508
Astellas Pharma US Inc
$350
Dendreon Pharmaceuticals LLC
$276
Endo Pharmaceuticals Inc.
$212
Teleflex LLC
$170
PROCEPT BioRobotics Corporation
$117
Sumitomo Pharma America, Inc.
$114
Janssen Products, LP
$100
Janssen Biotech, Inc.
$89
Boston Scientific Corporation
$67
Augmenix, Inc.
$42
Bayer HealthCare Pharmaceuticals Inc.
$35
MEDIVATION FIELD SOLUTIONS LLC
$32
PFIZER INC.
$28
Blue Earth Diagnostics Limited
$27
Tolmar, Inc.
$26
Coloplast Corp
$25
Myovant Sciences Inc.
$24
Myriad Genetic Laboratories, Inc.
$23
DENTSPLY IH Inc.
$22
UroGen Pharma, Inc.
$21
Photocure Inc
$21
UROVANT SCIENCES INC
$21
Antares Pharma, Inc.
$15
AbbVie Inc.
$15
Axonics, Inc.
$14
Hollister Incorporated
$14
BOSTON SCIENTIFIC CORPORATION
$13
Olympus America Inc.
$12
Allergan Inc.
$11
Allergan, Inc.
$11
Top 3 companies account for 46.1% of all-time payments
Associated products mentioned in payments ›
AQUABEAM SYSTEM · AVEED · Advantage System · Axonics · Axumin · BOTOX · CYSVIEW · ELIGARD · Erleada · GEMTESA · GENERAL KIDNEY STONE DISEASE · Infyna Chic · JELMYTO · LoFric · Lynx System · MYRBETRIQ · Nubeqa · ORGOVYX · PROLARIS · PROVENGE · REZUM · ShockPulse - SE · SpaceOAR · TITAN · UROLIFT · UroLift · XIAFLEX · XTANDI · XYOSTED · Xofigo · ZYTIGA · rezum Generator
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (86%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
Urology physicians within 10 mi
10
Per 100K population
9.9
County median income
$64,635
Nearest hospital
CAROLINA EAST MEDICAL CENTER
8.9 mi
8.9 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Doak is a clinical cardiology specialist, with above-average Medicare volume (top 29% in NC), with low-engagement industry engagement, with 17 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Doak experienced with urinalysis with microscopic exam?
Based on Medicare claims data, Dr. Doak performed 760 urinalysis with microscopic exam services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Doak receive payments from pharmaceutical companies?
Yes. Dr. Doak received a total of $2,457 from 31 companies across 93 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Doak's costs compare to other urology physicians in New Bern?
Dr. Doak's average Medicare payment per service is $48. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Doak) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Urology Physicians in New Bern
Browse urology physicians in New Bern ranked by procedure volume and transparency data.
Highest volume
Top Urology Physicians in NC
Urology physicians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Urology Physicians in NC
Which NC urology physicians receive the most from drug and device companies.
By company
NeoTract Inc. Payments to Doctors
See all physicians who received payments from NeoTract Inc.
By company
Astellas Pharma US Inc Payments to Doctors
See all physicians who received payments from Astellas Pharma US Inc.
By company
Dendreon Pharmaceuticals LLC Payments to Doctors
See all physicians who received payments from Dendreon Pharmaceuticals LLC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology